Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortization of Deferred ChargesAmortizatization of IntangiblesAmortizatization of IntangiblesCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in CashDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesGains from Sales and DivestituresGains from Sales and DivestituresNet Cash FlowNet Cash FlowNet IncomeNon-cash ItemsNon-cash ItemsShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Revolution Medicines (RVMD) Cash from Investing Activities (2019 - 2025)

Revolution Medicines has reported Cash from Investing Activities over the past 7 years, most recently at $74.9 million for Q4 2025.

  • Quarterly results put Cash from Investing Activities at $74.9 million for Q4 2025, up 119.06% from a year ago — trailing twelve months through Dec 2025 was $118.1 million (up 121.29% YoY), and the annual figure for FY2025 was $118.1 million, up 121.29%.
  • Cash from Investing Activities for Q4 2025 was $74.9 million at Revolution Medicines, up from $24.8 million in the prior quarter.
  • Over the last five years, Cash from Investing Activities for RVMD hit a ceiling of $107.9 million in Q2 2024 and a floor of -$392.9 million in Q4 2024.
  • Median Cash from Investing Activities over the past 5 years was -$2.4 million (2021), compared with a mean of -$47.3 million.
  • Biggest five-year swings in Cash from Investing Activities: surged 1806.67% in 2022 and later plummeted 6305.36% in 2024.
  • Revolution Medicines' Cash from Investing Activities stood at $8.5 million in 2021, then plummeted by 183.25% to -$7.1 million in 2022, then plummeted by 5254.76% to -$380.4 million in 2023, then decreased by 3.29% to -$392.9 million in 2024, then soared by 119.06% to $74.9 million in 2025.
  • The last three reported values for Cash from Investing Activities were $74.9 million (Q4 2025), $24.8 million (Q3 2025), and $34.3 million (Q2 2025) per Business Quant data.